Education
About Us
Working with TipRanks
Follow Us
Bioxyne Limited (AU:BXN)
:BXN
BXN Stock Chart & Stats
Day’s Range― - ―
52-Week Range<AU$0.01 - AU$0.05
Previous CloseN/A
Volume631.90K
Average Volume (3M)3.40M
Market Cap
AU$47.63M
Enterprise ValueAU$9.57M
Total Cash (Recent Filing)AU$2.65M
Total Debt (Recent Filing)AU$0.00
Price to Earnings (P/E)21.8
Beta0.85
Next Earnings
Aug 27, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding2,164,828,600
10 Day Avg. Volume3,028,450
30 Day Avg. Volume3,400,957
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)10.47
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Bioxyne Limited News
PremiumCompany Announcements
Bioxyne Limited Strengthens Advisory Board with Cannabis Expert
PremiumCompany Announcements
Bioxyne Secures $7M Exclusive Manufacturing Deal with NectarTek
PremiumCompany Announcements
Bioxyne Limited Completes Capital Raise with New Share Issuance
PremiumCompany Announcements
Bioxyne Limited Announces Quotation of New Securities on ASX
PremiumCompany Announcements
Bioxyne Limited Initiates Trading Halt Amid Capital Raising Efforts
PremiumCompany Announcements
Bioxyne Limited Announces Investor Webinar for March 2025
PremiumCompany Announcements
Bioxyne Limited Reports Strong Financial Recovery for 2024 Half-YearPremiumCompany Announcements
Bioxyne Limited Achieves Record Q2 Results, Plans Expansion into Europe---
BXN FAQ
What was Bioxyne Limited’s price range in the past 12 months?
Bioxyne Limited lowest share price was <AU$0.01 and its highest was AU$0.05 in the past 12 months.
What is Bioxyne Limited’s market cap?
Bioxyne Limited’s market cap is AU$47.63M.
When is Bioxyne Limited’s upcoming earnings report date?
Bioxyne Limited’s upcoming earnings report date is Aug 27, 2025 which is in 137 days.
How were Bioxyne Limited’s earnings last quarter?
Bioxyne Limited released its earnings results on Feb 27, 2025. The company reported AU$0.002 earnings per share for the quarter, beating the consensus estimate of N/A by AU$0.002.
Is Bioxyne Limited overvalued?
According to Wall Street analysts Bioxyne Limited’s price is currently Overvalued.
Does Bioxyne Limited pay dividends?
Bioxyne Limited does not currently pay dividends.
What is Bioxyne Limited’s EPS estimate?
Bioxyne Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Bioxyne Limited have?
Bioxyne Limited has 2,164,828,600 shares outstanding.
What happened to Bioxyne Limited’s price movement after its last earnings report?
Bioxyne Limited reported an EPS of AU$0.002 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Bioxyne Limited?
Currently, no hedge funds are holding shares in AU:BXN
---
Bioxyne Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:BXN Sentiment 70%
Sector Average 69%
Sector Average 69%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
―
20 days / 200 days
Momentum
118.18%
12-Months-Change
Fundamentals
Return on Equity
55.63%
Trailing 12-Months
Asset Growth
215.17%
Trailing 12-Months
Company Description
Bioxyne Limited
Bioxyne Limited, a life sciences and health products company, researches, develops, markets, and distributes dietary supplement and beauty products. It perates in two segments, Wholesale Sales and Direct Sales. The company engages in developing various functional foods and beauty products. Its products portfolio includes Progastrim for Gut and Immune Health; Progastrim plus Vitamin C for cold symptoms; and proTract for atopic dermatitis (eczema) for infants. The company provides its products online, as well as through wholesale and direct sales in the United States and Asia. Bioxyne Limited was incorporated in 1998 and is headquartered in Sydney, Australia.
---
Technical Analysis
Biotron Limited
―
Cynata Therapeutics Limited
―
Immutep Ltd
―
PYC Therapeutics Limited
―
InteliCare Holdings Limited
―
---